FDA Inspection 1238910 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on May 9, 2024 in El Paso, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 9, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- El Paso, TX (United States)